Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
[4] Clinical Applications of Melanocortin Peptides by R
Understanding where retatrutide stands requires understanding what makes it mechanistically distinct from its predecessors, where Phase 3 trials currently sit, what a realistic regulatory timeline looks like, and what options exist for patients who cannot or do not want to wait
Conclusions Based on a willingness-to-pay threshold of EUR 30,000 per QALY gained, oral semaglutide 14 mg represents a cost-effective option versus empagliflozin 25 mg and dulaglutide 1.5 mg for the treatment of people with type 2 diabetes with inadequate glycemic control on 12 OADs in Portugal
The program theoretically will expire at the end of 2027, although those taking GLP-1 drugs for obesity at that point are likely to advocate for its continuation
US$ 21.40
US$ 27.05
US$ 21.60
US$ 26.63
US$ 26.05
US$ 21.80
US$ 20.58
